share_log

Evercore ISI Group Maintains In-Line on Edwards Lifesciences, Raises Price Target to $92

Benzinga ·  Apr 5 00:38

Evercore ISI Group analyst Vijay Kumar maintains Edwards Lifesciences (NYSE:EW) with a In-Line and raises the price target from $86 to $92.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment